Startups
FibroBiologics is the world leader in cell therapy using fibroblasts to regenerate tissue and cure chronic diseases. Currently, FibroBiologics holds 150+ U.S. and international issued patents issued/pending across a variety of clinical pathways, including Disc Degeneration, Multiple Sclerosis, and Cancer. FibroBiologics represents the next generation of medical advancement in cell therapy.
Overview
Location
United States, Texas, Houston
Employees
11-50
Total raised
$100M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 14
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 28, 2025 | Ultra-fast EV charging bays coming to Waffle House locations in Texas and beyond | Scattered, smothered and ... charged? Starting next year, EV drivers can connect to ultra-fast charging stations at select Waffle House locations throughout Texas, courtesy of bp pulse. The EV arm of British energy giant bp announced a stra... |
| May 22, 2025 | Houston regenerative medicine company expands lab for future trials | A Houston regenerative medicine company has unveiled new laboratory space with the goal of expanding its pioneering science. FibroBiologics uses fibroblasts, the body’s most common type of cell, rather than stem cells, to help grow new cell... |
| Mar 14, 2025 | Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing | Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com NEW YORK, March 14, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the p... |
| Dec 30, 2024 | FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing | HOUSTON, Dec. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potentia... |
| Mar 17, 2023 | FibroBiologics Quickly Raises $5 Million StartEngine | FibroBiologics has quickly raised $5 million in a Reg CF securities offering on StartEngine. This is the maximum amount a company may raise under the securities exemption. The offering has been live for about four weeks so it was fully subs... |
| Nov 26, 2021 | Elon Musk taps into Texas workforce for out-of-this-world bartender gig | Can you mix a mean margarita? Are you capable of slinging a superb Aperol spritz? If so, Elon Musk wants you to become a "spaceport mixologist." Musk's SpaceX, which builds and launches rockets, is hiring a "passionate, exper... |
| Nov 26, 2021 | 5 most popular innovation stories in Houston this week | Editor's note: Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup news on InnovationMap included innovators to know, a Texas fund with fresh investment to su... |
| Nov 19, 2021 | 5 most popular innovation stories in Houston this week | Editor's note: Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup news on InnovationMap included innovators to know, fastest growing Houston tech companies, ... |
| Nov 18, 2021 | Houston health care company raises $100M and plans to IPO | A clinical stage therapeutic company has made some big moves — with an even bigger one on the horizon. FibroBiologics, which is developing fibroblast-based therapeutic cures for chronic diseases, announced $100 million in fresh funding resu... |
Show more
Reviews 0
FAQ about FibroBiologics
How much funding has FibroBiologics raised?
FibroBiologics has raised $100M in total across 1 funding round.
What has the press written about FibroBiologics?
Parsers VC has collected 14 articles mentioning FibroBiologics, among them “Ultra-fast EV charging bays coming to Waffle House locations in Texas and beyond” (May 28, 2025) and “Houston regenerative medicine company expands lab for future trials” (May 22, 2025).
Is FibroBiologics still active?
Yes, FibroBiologics is active; its latest activity on Parsers VC dates from Jun 4, 2025.